Pain and Self-Management Status Among Chinese Patients With Cancer During the COVID-19 Pandemic

Pain Manag Nurs. 2022 Feb;23(1):26-30. doi: 10.1016/j.pmn.2021.09.004. Epub 2021 Oct 4.

Abstract

Background: To investigate the pain and self-management status of patients with cancer and the influencing factors of pain and self-management status during the COVID-19 pandemic.

Methods: A cross-sectional design was used. Eighty-one Chinese patients with cancer were recruited in December 2020. The Brief Pain Inventory, the Pain Management Inventory, and the Pain Self-efficacy Questionnaire were used to evaluate patients' pain and self-management status. Descriptive statistical analysis and multiple linear regression models were conducted for the research aims.

Results: Two thirds of the participants experienced moderate to severe pain. Cancer pain had moderate to severe interference on 90.12% of patients' lives. Self-management of pain in these participants was low. The most commonly used methods of pain management included adjusting activity intensity to avoid fatigue, using distraction techniques, and massaging the sore area. The most effective methods to manage pain included taking analgesics prescribed by doctor, taking over-the-counter analgesics, and massaging the sore area. Fifteen patients (18.5%) believed that the COVID-19 pandemic had an impact on pain management and 26 patients (32.1%) needed support. Pain education, pain interference on sleep, chemotherapy, and payment status were significantly associated with cancer patients 'pain self-management.

Conclusions: During the COVID-19 pandemic, patients with cancer had moderate to severe pain intensity with low levels of self-management and self-efficacy towards that pain.

MeSH terms

  • COVID-19*
  • China / epidemiology
  • Cross-Sectional Studies
  • Humans
  • Neoplasms* / complications
  • Neoplasms* / therapy
  • Pain / drug therapy
  • Pain / epidemiology
  • Pandemics
  • SARS-CoV-2
  • Self-Management*